Exploratory neuropharmacological evaluation of a conformationally constrained thyrotropin-releasing hormone analogue. 2007

Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
Department of Molecular Biology and Immunology, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.

A conformationally constrained peptidomimetic derived from the endocrine and neuroactive tripeptide thyrotropin-releasing hormone (pGlu-His-Pro-NH(2)) was synthesized by convenient solid-phase organic chemistry and evaluated as a potential central nervous system agent. While this ethylene-bridged peptide analogue has been reported to lack the hormonal effect of the native peptide, we have shown in animal models that it possesses central nervous system activity characteristic of thyrotropin-releasing hormone. Compared to control, the peptidomimetic showed significant analeptic and antidepressant-like potencies. Moreover, an enhanced selectivity in antidepressant-like effect was measured when compared to that of the native peptide. Immobilized artificial membrane chromatography and in vitro metabolic stability studies also revealed that this constrained peptidomimetic has higher affinity to the blood-brain barrier than the native peptide and is metabolically stable. Consequently, this structure may be used as a template to design centrally selective and metabolically stable thyrotropin-releasing hormone analogues as potential neuropharmaceutical agents.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010424 Pentobarbital A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
March 1982, Regulatory peptides,
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
January 2013, Pharmaceutics,
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
November 1980, Science (New York, N.Y.),
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
January 1977, Naunyn-Schmiedeberg's archives of pharmacology,
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
November 2008, The Journal of organic chemistry,
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
February 1990, Biopolymers,
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
November 1999, Journal of medicinal chemistry,
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
December 1998, Bioorganic & medicinal chemistry,
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
October 1980, Archives internationales de pharmacodynamie et de therapie,
Meritxell Teixidó, and Katalin Prokai-Tatrai, and Xiaoli Wang, and Vien Nguyen, and Laszlo Prokai
January 1992, The Biochemical journal,
Copied contents to your clipboard!